These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35911346)

  • 21. [International reference prices and cost minimization analysis for the regulation of medicine prices in Colombia].
    Vacca C; Acosta A; Rodriguez I
    Value Health; 2011; 14(5 Suppl 1):S16-9. PubMed ID: 21839891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pricing and availability of some essential child specific medicines in Odisha.
    Swain TR; Rath B; Dehury S; Tarai A; Das P; Samal R; Samal S; Nayak H
    Indian J Pharmacol; 2015; 47(5):496-501. PubMed ID: 26600637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effects of a New Public Medicine Procurement Policy on Medicine Price in Shaanxi Province, Western China: An Interrupted Time Series Analysis.
    Hu S; Chen C; Yuan S; Xue F; Shi L; Fang Y; Yang C
    Front Pharmacol; 2019; 10():950. PubMed ID: 31555135
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
    Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
    PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prices of combination medicines and single-molecule antihypertensive medicines in India's private health care sector.
    Negi S; Neupane D; Sahoo SK; Mahajan T; Swaroop K; Moran AE; Sharma B; Pathni AK
    J Clin Hypertens (Greenwich); 2021 Apr; 23(4):738-743. PubMed ID: 33369089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term differences in drug prices after implementation of the national essential medicines system: A case study in rural Jiangxi Province, China.
    Wang J; Liu X; Wang S; Chen H; Wang X; Zhou W; Wang L; Zhu Y; Zheng X; Hao M
    Indian J Pharmacol; 2015; 47(5):535-9. PubMed ID: 26600644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between medicine Price declaration by pharmaceutical industries and retail prices in Malaysia's private healthcare sector.
    Ahmad NS; Hatah E; Makmor-Bakry M
    J Pharm Policy Pract; 2019; 12():15. PubMed ID: 31304021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
    Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
    Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.
    Aaserud M; Dahlgren AT; Kösters JP; Oxman AD; Ramsay C; Sturm H
    Cochrane Database Syst Rev; 2006 Apr; (2):CD005979. PubMed ID: 16625648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Cost Variation Analysis of Drugs Available in the Indian Market for the Management of Thromboembolic Disorders.
    Ray A; Najmi A; Khandelwal G; Sadasivam B
    Cureus; 2020 May; 12(5):e7964. PubMed ID: 32523821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. International comparison of generic medicine prices.
    Simoens S
    Curr Med Res Opin; 2007 Nov; 23(11):2647-54. PubMed ID: 17877848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmaceutical Policy Reforms to Regulate Drug Prices in the Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea.
    Hasan SS; Kow CS; Dawoud D; Mohamed O; Baines D; Babar ZU
    Value Health Reg Issues; 2019 May; 18():18-23. PubMed ID: 30414506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the National Centralized Drug Procurement Policy (4 + 7 policy) on the drug expenditures of patients treated in outpatient and emergency departments in a large tertiary level-A hospital in China: A single centre, interrupted time series.
    Lan T; Guan L; Pang X; Li X; Yu Q
    J Clin Pharm Ther; 2022 Jan; 47(1):104-111. PubMed ID: 34668203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pricing policies for generic medicines in Australia, New Zealand, the Republic of Korea and Singapore: patent expiry and influence on atorvastatin price.
    Roughead EE; Kim DS; Ong B; Kemp-Casey A
    WHO South East Asia J Public Health; 2018 Sep; 7(2):99-106. PubMed ID: 30136668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Price variation among different brands of anticancer medicines available in hospital pharmacies of Nepal.
    Shrestha S; Poudel RS; Kc B; Poudel BK; Sapkota B; Sharma S; Khadka A
    J Pharm Policy Pract; 2020; 13():6. PubMed ID: 32266073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of pharmaceutical tendering on prices and market concentration in South Africa over a 14-year period.
    Wouters OJ; Sandberg DM; Pillay A; Kanavos PG
    Soc Sci Med; 2019 Jan; 220():362-370. PubMed ID: 30513486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of Launch and Postapproval Cancer Drug Pricing, Clinical Benefit, and Policy Implications in the US and Europe.
    Vokinger KN; Hwang TJ; Daniore P; Lee CC; Tibau A; Grischott T; Rosemann TJ; Kesselheim AS
    JAMA Oncol; 2021 Sep; 7(9):e212026. PubMed ID: 34196656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Affordability of essential medicine prices in Malaysia's private health sector.
    Ahmad NS; Islahudin F
    Patient Prefer Adherence; 2018; 12():1231-1237. PubMed ID: 30038489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pricing and components analysis of some key essential pediatric medicine in Odisha state.
    Samal S; Swain TR
    Indian J Pharmacol; 2017; 49(1):89-92. PubMed ID: 28458429
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.